Teva to get U.S. rights to Andrx products

12/12/2003 | Ha'aretz (Tel Aviv, Israel)

Israel's Teva Pharmaceuticals will get exclusive marketing rights in the U.S. and Canada to Andrx's line of generic oral contraceptive products now awaiting regulatory approval. Financial terms were not disclosed, but analysts said the deal fills holes in Teva's product line and Andrx gets Teva's marketing channels.

View Full Article in:

Ha'aretz (Tel Aviv, Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC